Global Kidney Function Test Market

Global Kidney Function Test Market Size, Share, Growth Analysis, By Test(Clearance tests, Urine tests), By Product(Dipsticks, Disposables), By End-use(Diagnostic laboratories, Hospital’s) - Industry Forecast 2024-2031

Report ID: SQMIG35D2206 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 91 | Figures: 66

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Global Kidney Function Test Market size was valued at USD 805.08 million in 2021 and is poised to grow from USD 855 million in 2022 to USD 1383.45 million by 2030, growing at a CAGR of 6.2% in the forecast period (2023-2030).

The competitive environment of the global Kidney Function Test market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Abbott', 'Danaher', 'F. Hoffmann-La Roche Ltd.', 'Sysmex Corporation', 'Siemens Healthineers', 'Randox Laboratories Ltd', 'Quest Diagnostics', 'ACON Laboratories, Inc.', 'Nova Biomedical Corporation', 'Laboratory Corporation of America Holdings'

The Kidney function test market is poised to witness lucrative opportunities driven by technological advancements. One notable example is the groundbreaking innovation unveiled by Bloom Diagnostics in August 2022, introducing a smart system designed to detect an extensive array of medical disorders. Among its offerings, the Bloom Kidney Test stands out as the latest addition to its portfolio. This test revolutionizes Kidney health assessment by quantitatively measuring cystatin C levels in the bloodstream, facilitating the evaluation of Glomerular Filtration Rate (GFR) to determine Kidney functionality. Notably, the test provides a comprehensive assessment through three distinct classifications—indicating normal function, mildly decreased function, or decreased function—offering vital insights into Kidney health.

The burgeoning demand for home diagnostics, particularly evident in the increased adoption of digital urinalysis, is driving notable growth within the market. This trend reflects a significant shift towards convenient and accessible healthcare solutions. Notably, Healthy.io, an Israeli-based digital health startup, has astutely recognized this trajectory and developed an FDA-cleared at-home smartphone urinalysis test tailored for individuals seeking Kidney tests for proteins.

In 2022, North America emerged as the revenue leader, asserting dominance within the market landscape. This stronghold can be attributed to several factors, notably the region's well-established healthcare infrastructure, coupled with a heightened awareness of Chronic Kidney Disease (CKD) among both healthcare professionals and the general populace. Additionally, the region benefits from favorable reimbursement policies and proactive governmental initiatives aimed at bolstering healthcare accessibility and affordability.

Related Reports

Omics-Based Clinical Trials Market
Buy Now GET FREE SAMPLE
Global Cardiovascular Drugs Market
Buy Now GET FREE SAMPLE
Global Cartilage Repair Market
Buy Now GET FREE SAMPLE
Positron Emission Tomography Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Kidney Function Test Market

Product ID: SQMIG35D2206

$5,300
BUY NOW GET FREE SAMPLE